Drug intelligence / Profile preview

lidocaine + chlorprocaine

Development stage
Phase 4
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Epidural, Intrathecal, Local Infiltration, Peripheral Nerve Block
01

Overview

Lidocaine + chlorprocaine is a combination of two local anesthetics used primarily for regional or local anesthesia. Lidocaine is an amide-type local anesthetic that works by blocking sodium channels in neuronal cell membranes, thereby inhibiting nerve impulse conduction and producing loss of sensation in the targeted area[8]. Chlorprocaine is an ester-type local anesthetic with a rapid onset and short duration of action; it also blocks sodium channels to prevent nerve signal transmission[3][6][10]. The combination may be used to achieve rapid onset (from chlorprocaine) with sufficient duration (from lidocaine) for procedures requiring quick but effective anesthesia, such as certain surgical or obstetric interventions. Both agents act on the cardiovascular and central nervous systems at higher doses but are generally safe when administered appropriately. This combination does not have a unique brand name formulation but may be compounded for specific clinical uses.

Other names
lidocaine and chloroprocainelidocaine/chlorprocaine
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)

Beyond the preview

Go deeper on lidocaine + chlorprocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + chlorprocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call